Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease
Leonardo Elia, … , Gianluigi Condorelli, Manuela Quintavalle
Leonardo Elia, … , Gianluigi Condorelli, Manuela Quintavalle
Published June 1, 2018; First published March 20, 2018
Citation Information: J Clin Invest. 2018;128(6):2473-2486. https://doi.org/10.1172/JCI96121.
View: Text | PDF
Categories: Research Article Cell biology Vascular biology

UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease

  • Text
  • PDF
Abstract

Adult vascular smooth muscle cells (VSMCs) dedifferentiate in response to extracellular cues such as vascular damage and inflammation. Dedifferentiated VSMCs are proliferative, migratory, less contractile, and can contribute to vascular repair as well as to cardiovascular pathologies such as intimal hyperplasia/restenosis in coronary artery and arterial aneurysm. We here demonstrate the role of ubiquitin-like containing PHD and RING finger domains 1 (UHRF1) as an epigenetic master regulator of VSMC plasticity. UHRF1 expression correlated with the development of vascular pathologies associated with modulation of noncoding RNAs, such as microRNAs. miR-145 — pivotal in regulating VSMC plasticity, which is reduced in vascular diseases — was found to control Uhrf1 mRNA translation. In turn, UHRF1 triggered VSMC proliferation, directly repressing promoters of cell-cycle inhibitor genes (including p21 and p27) and key prodifferentiation genes via the methylation of DNA and histones. Local vascular viral delivery of Uhrf1 shRNAs or Uhrf1 VSMC-specific deletion prevented intimal hyperplasia in mouse carotid artery and decreased vessel damage in a mouse model of aortic aneurysm. Our study demonstrates the fundamental role of Uhrf1 in regulating VSMC phenotype by promoting proliferation and dedifferentiation. UHRF1 targeting may hold therapeutic potential in vascular pathologies.

Authors

Leonardo Elia, Paolo Kunderfranco, Pierluigi Carullo, Marco Vacchiano, Floriana Maria Farina, Ignacio Fernando Hall, Stefano Mantero, Cristina Panico, Roberto Papait, Gianluigi Condorelli, Manuela Quintavalle

×

Figure 1

Regulation of Uhrf1 expression in response to mediators contributing to VSMC phenotypic switching.

Options: View larger image (or click on image) Download as PowerPoint
Regulation of Uhrf1 expression in response to mediators contributing to ...
(A) Analysis of the expression of 96 epigenetic genes in PDGF-BB–treated primary murine VSMCs with microfluidic cards. After global normalization, the statistical analysis was performed on 2 experimental duplicates compared with control cells (grown in a serum-deprived condition) and plotted versus the values of fold changes. A gene was arbitrarily considered modulated if fold induction was <0.6 to >2 compared with control and if the P value of such a difference was less than 0.05. (B) RT-qPCR gene expression analysis of VSMCs treated with different stimuli. The control sample (0.1% FBS) was set as 1. Results are the average of at least 3 independent experiments, and error bars indicate SD. #P < 0.05. (C) Representative Western blot showing UHRF1 levels in VSMCs treated with PDGF-BB (25 ng/ml) or TGF-β (10 ng/ml). Unpaired 2-tailed Student’s t test was used to compare means for A, and 1-way ANOVA with Tukey’s multiple comparisons test was used for B. #Adjusted P < 0.05.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts